Efficacy and Safety of Ombitasvir, Paritaprevir and Ritonavir plus Ribavirin in Hepatitis C Genotype-4 Patients on Hemodialysis

Comparing The Efficacy and Safety of (Ombitasvir/ Paritaprevir/ Ritonavir) in Management of Chronic HCV Patients Among Haemodialysis Patients and Those with Normal Renal Functions

Safety and Efficacy of Ombitasvir, Paritaprevirand Ritonavir Combination with Ribavirin for Treatment of Chronic Hepatitis C Virus in Advanced Kidney Diseases Patients in Upper E

Efficacy and Safety of Omibtasvir, Paritaprevir and Ritonavir Combination with Ribavirin for Treatment of Chronic Hepatitis C Patients

Evaluation of the Clinical Effects of Ombitasvir/Paritaprevir/ Ritonavir Regimen in the Treatment of Chronic HCV Patients in CKD Versus ESRD Patients in Assiut University Hospital

The Efficacy and Safety of Treatment of Chronic HCV Infection by Ombitasvir/Paritaprevir/Ritonavir with Ribavirin and its Effect on Complement C3 and C4 Levels

Pegylated Interferon Alfa 2a and Small Dose Ribavirin in The Treatment of HCV Genotype 4 in End-stage Renal Disease

Outcome of Decompensated Hepatitis C Virus Cirrhotic Patients Treated with Direct Acting Antiviral Drugs

Efficacy of Sofosbuvir-Daclatasvir in Treatment of Chronic Hepatitis C Virus Infection

Efficacy and Adverse Effects of Sofosbuvir-Based Therapies (Double and Triple Regimens) in Chronic HCV Patients